Overview

[F-18] RGD-K5 Positron Emission Tomography (PET) in Participants With Carotid Artery Stenosis

Status:
Terminated
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
This trial will be the first trial for the Investigation Product (IP), [F-18]RGD-K5 for carotid plaque imaging and will be conducted as a Phase II trial since this compound has already been tested in humans for phase I and phase II imaging. All study results will be evaluated and analyzed in order to consider the design for future clinical trials.
Phase:
Phase 2
Details
Lead Sponsor:
Siemens Molecular Imaging